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ABSTRACT
Questions remain about whether the increased risk of fractures in patients with type 2 diabetes (T2DM) is relatedmainly to increased
risk of falling or to bone-specific properties. The primary aim of this study was to investigate the risk of hip fractures and non-skeletal
fall injuries in older men and women with and without T2DM. We included 429,313 individuals (aged 80.8 8.2 years [mean SD],
58% women) from the Swedish registry “Senior Alert” and linked the data to several nationwide registers. We identified 79,159
individuals with T2DM (45% with insulin [T2DM-I], 41% with oral antidiabetics [T2DM-O], and 14% with no antidiabetic treatment
[T2DM-none]) and 343,603 individuals without diabetes. During a follow-up of approximately 670,000 person-years, we identified in
total 36,132 fractures (15,572 hip fractures) and 20,019 non-skeletal fall injuries. In multivariable Cox regression models where the
reference group was patients without diabetes and the outcome was hip fracture, T2DM-I was associated with increased risk
(adjusted hazard ratio (HR) [95% CI] 1.24 [1.16–1.32]), T2DM-O with unaffected risk (1.03 [0.97–1.11]), and T2DM-none with reduced
risk (0.88 [0.79–0.98]). Both the diagnosis of T2DM-I (1.22 [1.16–1.29]) and T2DM-O (1.12 [1.06–1.18]) but not T2DM-none (1.07 [0.98–
1.16]) predicted non-skeletal fall injury. The same pattern was found regarding other fractures (any, upper arm, ankle, and major
osteoporotic fracture) but not for wrist fracture. Subset analyses revealed that in men, the risk of hip fracture was only increased in
those with T2DM-I, but in women, both the diagnosis of T2DM-O and T2DM-I were related to increased hip fracture risk. In
conclusion, the risk of fractures differs substantially among patients with T2DM and an increased risk of hip fracture was primarily
found in insulin-treated patients, whereas the risk of non-skeletal fall injury was consistently increased in T2DM with any diabetes
medication. © 2016 American Society for Bone and Mineral Research.
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Introduction
The United Nations estimates that within the next 30 years,the global life expectancy will increase substantially(1) and as
a consequence, age-associated diseases are expected to
increase. Diabetes is by far one of the world’s largest health
challenges of this time, affected not only by age itself but most
of all by lifestyle changes such as increased access to high-
energy rich food and less expenditures. The International
Diabetes Federation estimates that in 2015, approximately 415
million people suffered from diabetes, and this figure is
expected to reach 642 million in 2040. Type 2 diabetes
(T2DM) accounts for more than 90% of all individuals with
diabetes, and more than 94 million people with diabetes are
ages 65 to 79 years.(2)
In parallel, there is another age-related epidemic ongoing as
osteoporosis is estimated to affect 200 million women
worldwide, and approximately 1.6 million hip fractures, the
most severe of the osteoporotic fractures, occur annually.(3)
Traditionally, T2DM has not been considered as a risk factor for
osteoporotic fractures and studies have shown that patients
with T2DM have normal or increased bone mineral density
(BMD) compared with non-diabetic controls.(4) Nevertheless,
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several studies,(5–9) but not all,(10,11) have reported an increased
risk of hip fractures among patients with T2DM. A decade ago,
two large meta-analyses presented unanimously that both type
1 diabetes (T1DM) and T2DM were related to increased risk of
hip fracture, although the relationship was more profound for
T1DM and BMD was indeed higher in patients with T2DM.(12,13)
Recently, an updated meta-analysis including 21 studies
confirmed the previous results, and patients with T2DM had
approximately 30% increased risk of hip fracture compared with
non-diabetic individuals.(14) However, many of the studies that
were included in these meta-analyses were fairly small with a
limited number of fractures and sometimes not well character-
ized even regarding type 1 or type 2 diabetes. In addition,
because T2DM represents a heterogeneous disorder, it seems
reasonable not classifying all patients into the same group
without taking into consideration disease severity or antidia-
beticmedications. Furthermore, many previous studies included
patients that were aged 60 to 70 years and the incidence peak
for hip fractures occurs in much older patients.(15)
To date, the underlying reasons for the association between
diabetes and fractures remain unclear. Evidence has been
presented regarding alterations in bone microarchitecture,
bone turnover, and osteogenic cells, but other extra-skeletal
factors such as medications, disturbed vision, impaired muscle
strength, intensive glycemic control, and frequent falls may be
just as important.(16) Patients with diabetes have indeed an
increased risk of falling.(17) However, none of the previous
studies exploring the risk of hip fractures have presented data on
coincident risk for other non-skeletal fall-related injuries. To be
able to improve risk assessment and for better understanding of
the complex relationship between T2DM and fractures, further
studies in this area are warranted.
The primary aim of this study was to investigate the risk of hip
fractures and non-skeletal fall injuries in patients with T2DM,
collected from a large cohort of elderly patients with information
regarding comorbidities, antidiabetic medications, and assess-
ment of risk of falling. As a secondary aim, we investigated the




The Fractures and Fall Injuries in the Elderly Cohort (FRAILCO) is a
patient-based cohort study where Swedish national directories
are linked in order to study associations regarding fractures, fall
injuries, morbidity, mortality, and medications. The cohort
consists of 429,313 men and women (aged 80.8 8.2 years
(mean SD), range 65–109 years, 58% women) included
between 2008 and 2014 in the Swedish national directory
“Senior Alert.”(18) Patients were followed from the time of
registration until death, emigration, or the end of 2014, resulting
in approximately 670,000 person-years with a median follow-up
time of 1.3 years (interquartile range 0.6–2.3). The directory was
originally designed to serve as a quality registry to support
improvements in preventive care for older adults and includes
more than 20% of the entire Swedish population in this age
group. Swedish citizens aged 65 years or older were registered in
connection to a visit to a health care facility by a licensed allied
health professional, regardless of diagnosis, comorbidities,
functioning, and health. In the end of 2014, more than 90% of
all municipalities in Sweden were connected to Senior Alert, and
all participants were registered with information about age, sex,
height, and weight along with a number of parameters related
to the risk of falling, pressure ulcers, and nutrition. Information
concerning medications, diagnoses, fall injuries, fractures, and
deaths, in relation to time of registration, were collected using
the Drug Dispensation Register (2005–2014), the Patient
Register (2001–2014 for outpatient visits and 1987–2014 for
admitted patients), and Cause of Death Register. Information
regarding immigration and emigration was included from
Statistics Sweden. The study was approved by the regional
ethical review board in Gothenburg.
Procedures
We defined “treatment with insulin” as any known prescriptions
of insulin and “treatment with oral antidiabetics” as any
prescription of non-insulin antidiabetics (including injectable
GLP-1 analogues) in the Drug Dispensation Register. Because
many patients receive their diagnosis of type 2 diabetes in
primary-care units and thus not included in the Patient Register
and because of possible misclassifications between ICD E10 to
E11, patients were classified as type 1 diabetes if they were
diagnosedwith E10 and had received prescriptions of insulin but
no other non-insulin antidiabetic medications. We subsequently
defined type 2 diabetes as all other patients with diabetes, based
on either a diagnosis of E10 with oral antidiabetics, E11, or
without any diagnosis but with known prescriptions of
antidiabetic medications. If patients were diagnosed as E10
(type 1 diabetes) but had no prescriptions of any antidiabetic
medications in the register, they were classified as diabetes
unknown (n¼ 1008) andexcluded fromthepresent study (Fig. 1).
Outcomes
Incident hip fracture was defined as a fractured femoral head,
neck, trochanter, or subtrochanteric part of femur, in combina-
tion with a code for surgical procedure (ICD codes in
Supplemental Tables S1 and S2) that occurred after the
registration to Senior Alert. To further ascertain that the defined
combination of codes represented a new hip fracture and not a
previous hip fracture with a revisit, the second fracture was
discarded if the codes were repeated within 5 months. Incident
non-skeletal fall injury was classified as any injury (except
fractures) occurring after the time of inclusion that was
accompanied by a code representing a fall (ICD codes in
Supplemental Table S3). As a secondary aim, we investigated
relationships to other non-hip fractures (any fracture, wrist,
upper arm, major osteoporotic fracture [MOF], and ankle), which
were defined in the same procedures as above and as specified
in Supplemental Table S1. We did not include vertebral fracture
in the study because these fractures are seldom diagnosed and
have a low rate of registration in Swedish registers.
Comorbidities
Comorbidities were defined according to ICD codes specified in
Supplemental Table S4. From the Senior Alert questionnaire,
99% of the registered individuals provided information regard-
ing previous known falls (yes/no), which was used as a surrogate
marker for risk of falling. Previous glucocorticoid treatment was
defined as any previous period the patient had retrieved
prescriptions for more than 450mg of prednisolone or
equivalents during three months or more (Supplemental
Table S5). For the survival analyses, Charlson comorbidity
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index(19) (excluding diabetes) was used to quantify comorbidity.
The index was calculated as a weighted sum of the following
diseases (ICD-10 codes in Supplemental Table S6): one point
each for dementia, ischemic heart disease, congestive heart
failure, cerebrovascular disease, disease of arteries, arterioles,
and capillaries, chronic pulmonary disease, chronic liver disease;
one point for mild renal failure and an extra point if severe renal
failure; two points each for hemiplegia, peptic ulcer disease,
tumor without metastasis, lymphoma, or leukemia; and six
points for metastatic solid tumor. Characterization of general
condition, food, and liquid intake at the time of risk assessment
was performed using questions from the validated RAPS or
Norton scales(20) used in Senior Alert for risk assessment of
decubitus ulcers.
Statistical analysis
Age and bodymass index (BMI) are presented asmean SD and
all comorbidities as proportions.We used Cox proportional time-
dependent hazards models to estimate hazards for the different
groups of diabetes and the outcomes, and for the survival
analyses, the reference group was patients without diabetes. To
adjust for comorbidities, all models were adjusted for age, sex,
height, and weight (multivariate 1) and as a second step we
introduced traditional risk factors into the models (age, sex,
height, weight, previous fracture, rheumatoid arthritis, gluco-
corticoid use, alendronate use), including Charlson comorbidity
index (multivariate 2). Ultimately, we added previous self-
reported known fall injury as an estimate of risk for falling
(multivariate 3). In the analyses where men and women were
compared within the same corresponding diabetes group, the
models were fully adjusted (multivariate 3). All statistical
analyses were performed using IBM SPSS version 23.
Results
We identified 79,159 patients with T2DM (41% with only oral
antidiabetics [T2DM-O], 45%with insulin [T2DM-I], and 14% with
no antidiabetic medications [T2DM-none]), 5543 patients with
T1DM, and 343,603 patients without diabetes. The baseline
characteristics of the different groups in the cohort are presented
in Table 1. In summary, patients with diabetes were younger, had
higher BMI, andhada lowerproportionofwomencomparedwith
patients without diabetes. During the study period, 47%
(n¼ 2588) of the patients with T1DM and 36% (n¼ 28,499) of
the patients with T2DM died compared with 34% (n¼ 115,264)
among patients without diabetes. There were no major differ-
ences in general health (based on the RAPS and Norton scales)
between the groups because a majority of all patients were
classified as in fairly good condition, eating three-quarters of a
portion and drinking more than 700mL a day. The patients with
T2DM had less frequently experienced a previous fracture and
those with T1DM had more previous fractures in the history
compared with those without diabetes. Patients with diabetes
(T1DM or T2DM) had a much higher frequency of all investigated
comorbidities except for rheumatoid arthritis and dementia,
which were less frequent in patients with T2DM than in patients
without diabetes. Among patients with antidiabetic medications,
there were more patients with prescriptions of metformin in the
group with T2DM-O compared with T2DM-I, but the groups had
similar prescriptions of sulphonylurea, pioglitazone, and sitaglip-
tin. Patients with insulin treatment were more frequently
diagnosed with retinopathy and the same pattern was found
regarding diagnosis of “any diabetes complication” (Table 1).
Baseline characteristics of the cohort subdivided according to
sex are presented in Table 2. Women were older and had to a
larger extent suffered from a previous fracture (which was
Fig. 1. Flow chart of the entire cohort. Accepted values after exclusion of top and bottom 1% were weight 30–176 kg, height 114–197 cm, and BMI
12.23–73.05 kg/m2.
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Age, years (mean SD) 81.1 (8.3) 80.6 (7.8) 79.4 (7.6) 79.3 (7.7) 78.8 (7.7)
Sex (% females) 203,567 (59%) 6006 (54%) 16,503 (51%) 17,953 (50%) 2660 (48%)
BMI kg/m2 (mean SD) 24.9 (4.8) 26.4 (5.3) 27.1 (5.2) 28.3 (5.7) 26.3 (5.2)
Inclusion site
Hospital 218,034 (63%) 7876 (71%) 21,893 (68%) 22,020 (61%) 3560 (64%)
Nursing home 84,023 (24%) 1967 (18%) 5966 (19%) 8403 (23%) 1246 (22%)
Primary care center 13,348 (3.9%) 424 (3.8%) 1480 (4.6%) 1487 (4.1%) 213 (3.8%)
Residential home service 18,469 (5.4%) 497 (4.5%) 1904 (5.9%) 2914 (8.1%) 355 (6.4%)
Rehab unit 9630 (2.8%) 276 (2.5%) 883 (2.7%) 1142 (3.2%) 168 (3.0%)
General health description
General condition (good or
fairly good)
308,021 (90%) 9820 (90%) 28,793 (90%) 31,460 (88%) 4829 (88%)
Nutrition (3/4 portion or more) 273,249 (80%) 8939 (82%) 26,220 (82%) 29,472 (83%) 4455 (81%)
Drinking (>700mL/d) 305,005 (89%) 9959 (91%) 29,083 (91%) 32,797 (92%) 5040 (92%)
Previous events
Any fracture 112,690 (33%) 3385 (31%) 8702 (27%) 10,449 (29%) 2069 (37%)
Hip fracture 31,689 (9.2%) 892 (8.1%) 2216 (6.9%) 2457 (6.8%) 553 (10%)
Major osteoporotic fracture 73,582 (21%) 2127 (19%) 5199 (16%) 6057 (17%) 1253 (23%)
Diagnosis of fall injury 116,421 (34%) 3609 (33%) 9377 (29%) 11,350 (32%) 2187 (39%)
Self-reported fall injury (yes/no) 136,754 (40%) 4329 (40%) 12,658 (40%) 14,892 (42%) 2383 (44%)
Incident events
Death 115,264 (34%) 3929 (36%) 10,082 (31%) 14,488 (40%) 2588 (47%)
Fractures
Any 29,604 (8.6%) 844 (7.6%) 2295 (7.1%) 2771 (7.7%) 530 (9.6%)
Hip 12,926 (3.8%) 331 (3.0%) 944 (2.9%) 1119 (3.1%) 218 (3.9%)
Wrist 1825 (0.5%) 52 (0.5%) 98 (0.3%) 128 (0.4%) 23 (0.4%)
Upper arm (chollum chir.) 2261 (0.7%) 74 (0.7%) 205 (0.6%) 244 (0.7%) 60 (1.1%)
Major osteoporotic fracture 17,718 (5.2%) 505 (4.6%) 1320 (4.1%) 1580 (4.4%) 312 (5.6%)
Ankle 828 (0.2%) 31 (0.3%) 83 (0.3%) 121 (0.3%) 27 (0.5%)
Non-skeletal fall injury 16,193 (4.7%) 568 (5.1%) 1497 (4.9%) 1761 (4.9%) 281 (5.1%)
Comorbidities
Rheumatoid arthritis 8785 (2.6%) 256 (2.3%) 689 (2.1%) 918 (2.6%) 169 (3.0%)
Dementia 36,255 (11%) 1243 (11%) 2798 (8.7%) 3500 (10%) 706 (13%)
Neurological diseases 96,846 (28%) 4222 (38%) 9438 (29%) 11,073 (31%) 2495 (45%)
Hypertension 139,780 (41%) 8261 (75%) 18,522 (58%) 20,812 (58%) 4287 (77%)
Ischemic heart disease 70,857 (21%) 4484 (41%) 9217 (29%) 11,351 (32%) 2600 (47%)
Heart arrhythmias 80,263 (23%) 4448 (40%) 8530 (27%) 9655 (27%) 1967 (35%)
Congestive heart failure 50,837 (15%) 3362 (30%) 6150 (19%) 8842 (25%) 1929 (35%)
Stroke 47,969 (14%) 2665 (24%) 5347 (17%) 6562 (18%) 1422 (26%)
Chronic obstructive pulmonary
disease
25,220 (7.3%) 1287 (12%) 2411 (7.5%) 2906 (8.1%) 523 (9.4%)
Chronic liver disease 3413 (1.0%) 245 (2.2%) 471 (1.5%) 734 (2.0%) 201 (3.6%)
Renal failure 16,587 (5%) 1390 (13%) 2203 (7%) 4865 (14%) 1282 (23%)
Malignant tumor (any) 152,120 (44%) 6517 (59%) 14,768 (46%) 16,948 (47%) 3991 (72%)
Diabetes retinopathy — 560 (5.1%) 3016 (9.4%) 8521 (24%) 3208 (58%)
Diagnosis of diabetes
complication
— 1262 (11%) 5356 (17%) 13,200 (37%) 4329 (78%)
Medications
Glucocorticoids 42,383 (12%) 1432 (13%) 3675 (11%) 5392 (15%) 770 (14%)
Alendronate 34,079 (9.9%) 924 (8.4%) 2099 (6.5%) 2515 (7.0%) 498 (9.0%)
Metformin — — 26,769 (83%) 25,500 (71%) —
Sulphonylurea — — 13,613 (42%) 15,202 (42%) —
Pioglitazone — — 1169 (3.6%) 1486 (4.1%) —
Sitagliptin — — 1465 (4.6%) 1699 (4.7%) —
Patients divided into those without diabetes, those with T2DM and insulin treatment (T2DM-I), T2DM and oral antidiabetics (T2DM-O), and T2DM
without any antidiabetic medicines (T2DM-none) or T1DM.
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consistent for all fracture types) compared with men. Further-
more, women had a larger number of incident fractures during
follow-up and very few men were treated with alendronate
(Table 2).
The most common non-skeletal fall injuries in regard to
location, type of injury, and mechanism of injury are presented
in Table 3. There were no clinically significant differences among
patients with diabetes compared with non-diabetic individuals.
The most common locations for any fall injury were head, hip
and thigh, abdomen, lower back, lumbar spine, and pelvis. The
most common types of injury were superficial wounds, open
wounds, andmuscle and tendon injury, and the vastmajority fell
from the same level, including slipping, tripping, or stumbling.
In Cox regression models adjusted for age, sex, height, and
weight and compared with patients without diabetes, the
diagnosis of T2DM was associated with an increased risk of hip
fracture (adjusted hazard ratio [HR] 1.10 [95% CI 1.05–1.15]) and
of non-skeletal fall injury (1.20 [1.15–1.24]). When the models
were adjusted for insulin use, the diagnosis itself was still related
to non-skeletal fall injury (1.13 [1.08–1.18]) but not to hip
fracture (0.99 [0.94–1.05]).
Table 4 presents all the crude incidence rates and adjusted
hazard ratios for incident fractures (both hip and other fractures)
and non-skeletal fall injury among the different groups of
diabetes compared with patients without diabetes. Patients
with insulin treatment (regardless of T1DM or T2DM) had
increased risk of any of the investigated fracture types (any
fracture, hip, upper arm, ankle, and MOF) except for wrist
fracture where the risk was not increased. Compared with
patients without diabetes, patients with T2DM-none had a
significantly lower risk of hip fracture and those with T2DM-O
had a significantly lower risk of wrist fracture. Furthermore, all
patients with any anti-diabetic medications (T1DM, T2DM-I or
T2DM-O) had consistently increased risk of upper arm fracture.
All patients with diabetes and any anti-diabetic medication had
increased risk for having a non-skeletal fall injury. There was a
trend where patients with insulin treatment had the highest risk
for fractures and fall injury and those with no anti-diabetic
medications had the lowest risk (Table 4). Survival curves
corresponding to the final models for patients with T2DM are
presented in Fig. 2A–F.
Subset analyses in which patients were divided according to
sex are presented in Table 5. In general, the risks of having
different fractures or non-skeletal fall injury in the different
diabetes groups followed the same pattern as in the whole
cohort. There were, however, some sex-specific differences
as men with diabetes but without insulin treatment did not
have increased risk of having any fracture, and men
without antidiabetic medications (T2DM-none) had significantly
decreased risk of having a hip fracture (adjusted HR 0.78 [95% CI
0.64–0.94]) compared with men without diabetes. In contrast,
among women, the risk of having any fracture or hip fracture
was slightly increased even in patients with oral antidiabetic
medications, and for both men and women, there was an
increased risk for non-skeletal fall injury in all patients receiving
any antidiabetic medications.
After multivariate adjustment (multivariate 3) where women
were compared with men within the same diabetes group,
women with T2DM-O (adjusted HR 1.26 [95% CI 1.04–1.53]) or
T2DM-I (1.42 [1.19–1.69]) had increased risk of hip fracture
compared with men, but for patients with no antidiabetic
medications, there was no statistically significant relationship
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non-skeletal fall injury, there was no significant association
between sex and the outcome within the three groups with
T2DM (data not shown).
Among patients with T2DM (n¼ 79,159), all available
antidiabetic medications were forced into a multivariable Cox
regression model adjusted for age, sex, weight, height, previous
fracture, rheumatoid arthritis, glucocorticoid and alendronate
use, and Charlson comorbidity index. In the model, insulin use
was associated with an increased risk of hip fracture (HR 1.24
[95% CI 1.14–1.35]), whereas metformin (1.05 [0.96–1.14]),
sulphonylurea (1.06 [0.98–1.15]), sitagliptin (0.85 [0.64–1.12]),
and pioglitazone (1.17 [0.93–1.47]) were not. In the samemodel,
butwith non-skeletal fall injury as outcome variable, insulin (1.13
[1.06–1.20]) and metformin (1.16 [1.10–1.22]) were indepen-
dently associated with increased risk, whereas sulphonylurea
(0.96 [0.90–1.02]), sitagliptin (0.98 [0.81–1.20]), and pioglitazone
(0.88 [0.72–1.07]) were not.
Among all patients with diabetes (T1DM or T2DM,
n¼ 84,702), adjusted for age, sex, height, and weight, the
presence of any diabetes complication was related to
increased risk of hip fracture (1.16 [1.06–1.26]), and this was
similar for diabetes retinopathy (1.17 [1.06–1.29]). When the
analyses were adjusted for insulin medication, the relation-
ships between these two variables and hip fracture remained
but were no longer statistically significant (1.08 [0.99–1.18])
and 1.09 [0.99–1.20]).
Discussion
The main findings from this study were that the risk of fractures
differs substantially among patients with diabetes and that
patients with T2DM and any kind of antidiabetic medications
had increased risk of having a non-skeletal fall injury compared
with patients without diabetes. Thus, only those with insulin
treatment had significantly increased risk of hip fracture
compared with non-diabetic individuals and those without
any antidiabetic medications had in fact reduced risk of hip
fracture despite increased comorbidities.
The same pattern of increased risk in those with insulin
treatment was also found when analyzing other fractures such
as any fracture, ankle, or MOF. However, all patients with any
(oral and/or insulin) antidiabetic treatment had significantly
increased risk of upper arm fracture, and in women the risk of
having any fracture or hip fracture was slightly increased even in
those with oral antidiabetics. Moreover, when the multivariable
models were adjusted for known previous falls, the hazards for
future fractures were slightly further reduced. This emphasizes
the substantial increased risk of falling in this patient group and,
furthermore, the heterogeneity among patients with T2DM that
this needs to be taken into consideration for appropriate
fracture risk assessment.
These results could be interpreted as already in less severe
stages of diabetes, the risk of falling is increased, and when the












Total number of non-skeletal fall injury 16,193 568 1497 1761 281
Location of injury
Head 6667 (41%) 213 (38%) 627 (42%) 647 (37%) 112 (40%)
Hip and thigh 3737 (23%) 128 (23%) 317 (21%) 428 (24%) 58 (21%)
Abdomen, lower back, lumbar spine, and
pelvis
1208 (7.5%) 45 (7.9%) 110 (7.3%) 137 (7.8%) 20 (7.1%)
Knee and lower leg 1135 (7.0%) 31 (5.5%) 103 (6.9%) 159 (9.0%) 22 (7.8%)
Shoulder and upper arm 1125 (6.9%) 47 (8.3%) 93 (6.2%) 116 (6.6%) 19 (6.8%)
Thorax 843 (5.2%) 33 (5.8%) 89 (5.9%) 98 (5.6%) 17 (6.0%)
Elbow and forearm 525 (3.2%) 20 (3.5%) 40 (2.7%) 49 (2.8%) 10 (3.6%)
Wrist and hand 468 (2.9%) 14 (2.5%) 35 (2.3%) 37 (2.1%) 7 (2.5%)
Ankle and foot 288 (1.8%) 9 (1.6%) 30 (2.0%) 42 (2.4%) 4 (1.4%)
Type of injury
Superficial wound 8034 (50%) 275 (48%) 718 (48%) 917 (52%) 150 (53%)
Muscle and tendon injury 3244 (20%) 111 (20%) 319 (21%) 329 (19%) 50 (18%)
Open wound 3138 (19%) 106 (19%) 258 (17%) 286 (16%) 53 (19%)
Dislocation, sprain, or strain of joints and
ligaments
866 (5.3%) 31 (5.5%) 91 (6.1%) 96 (5.5%) 5 (1.8%)
Mechanism of injury
Fall on same level from slipping, tripping,
and stumbling
9040 (56%) 323 (57%) 808 (54%) 933 (53%) 149 (53%)
Unspecified fall 4485 (28%) 133 (23%) 440 (29%) 496 (28%) 74 (26%)
Other fall on same level 874 (5.4%) 36 (6.3%) 77 (5.1%) 103 (5.8%) 18 (6.4%)
Fall involving bed 690 (4.3%) 32 (5.6%) 55 (3.7%) 84 (4.8%) 15 (5.3%)
Fall on and from stairs and steps 507 (3.1%) 22 (3.9%) 49 (3.3%) 52 (3.0%) 8 (2.8%)
Fall involving wheelchair 322 (2.0%) 15 (2.6%) 30 (2.0%) 57 (3.2%) 11 (3.9%)
Fall involving chair 217 (1.3%) 12 (2.1%) 20 (1.3%) 28 (1.6%) 6 (2.1%)
Patients divided into those with T2DM and insulin treatment (T2DM-I), T2DM and oral antidiabetics (T2DM-O), and T2DM without any antidiabetic
medicines (T2DM-none) compared with patients without diabetes. Values are presented as no. (% of total number of non-skeletal fall injuries) if not
stated otherwise.
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disease progresses and becomesmore severe, the risk of fracture
is ultimately increased, possibly because of direct adverse
skeletal effects. It is known that patients with diabetes have
increased risk of falling(17) and in accordance with our results but
from amuch smaller study, diabetes stratified by insulin use was
associated with an increased risk of falling.(21) Furthermore, a
recent meta-analysis showed a strong relationship between
hypoglycemia and the risk of future falls and fractures(22) and
this may in part explain the increased risk among patients
treated with insulin. Another possible explanation for the
increased risk of falls and fractures among insulin-treated
patients may be that diabetes treatment may represent a
surrogate marker for diabetes duration and disease severity.
Indeed, a recent study presented that patients with T2DM and
inadequate glucose control had increased risk of hip fracture,(23)
and diabetes duration has been associated with increased
fracture risk.(24) Nevertheless, as diabetes progresses, patients
develop comorbidities such as renal failure, visual impairment,
and neuropathy, as well as foot problems and possible
accelerated cognitive disorders known to increase fracture















5505 4568 4610 5239 6444
Multivariate 1 Reference 0.95 (0.88–1.01) 1.02 (0.98–1.06) 1.21 (1.17–1.26) 1.42 (1.30–1.55)
Multivariate 2 Reference 0.95 (0.88–1.02) 1.03 (0.99–1.08) 1.21 (1.16–1.25) 1.34 (1.23–1.47)




2404 1791 1896 2115 2650
Multivariate 1 Reference 0.89 (0.80–1.00) 1.04 (0.97–1.11) 1.25 (1.18–1.33) 1.44 (1.26–1.65)
Multivariate 2 Reference 0.88 (0.79–0.98) 1.03 (0.97–1.11) 1.24 (1.16–1.32) 1.38 (1.21–1.58)




339 281 197 242 280
Multivariate 1 Reference 0.97 (0.74–1.28) 0.72 (0.59–0.88) 0.95 (0.79–1.14) 1.04 (0.69–1.58)
Multivariate 2 Reference 0.96 (0.73–1.27) 0.73 (0.59–0.89) 0.94 (0.78–1.13) 0.97 (0.64–1.47)
Multivariate 3 Reference 0.94 (0.71–1.24) 0.70 (0.56–0.86) 0.92 (0.77–1.11) 0.93 (0.61–1.41)
Upper arm (collum chir.)
Incidence rate/100,000
person-years
420 400 412 461 729
Multivariate 1 Reference 1.10 (0.870–1.38) 1.16 (1.01–1.34) 1.36 (1.19–1.56) 2.10 (1.62–2.71)
Multivariate 2 Reference 1.08 (0.86–1.36) 1.18 (1.02–1.36) 1.33 (1.17–1.53) 1.88 (1.45–2.43)




3295 2733 2652 2987 3793
Multivariate 1 Reference 0.97 (0.89–1.06) 1.01 (0.96–1.07) 1.21 (1.15–1.28) 1.45 (1.29–1.62)
Multivariate 2 Reference 0.96 (0.88–1.05) 1.01 (0.96–1.07) 1.20 (1.14–1.26) 1.36 (1.22–1.53)




154 168 167 229 328
Multivariate 1 Reference 1.04 (0.72–1.48) 1.01 (0.80–1.27) 1.28 (1.05–1.55) 2.08 (1.42–3.06)
Multivariate 2 Reference 1.03 (0.72–1.47) 1.02 (0.82–1.29) 1.27 (1.04–1.54) 1.93 (1.31–2.84)




3011 3074 3007 3329 3416
Multivariate 1 Reference 1.13 (1.4–1.23) 1.14 (1.08–1.21) 1.29 (1.23–1.36) 1.30 (1.15–1.46)
Multivariate 4 Reference 1.07 (0.98–1.16) 1.12 (1.06–1.18) 1.22 (1.16–1.29) 1.13 (1.00–1.27)
Values are expressed as crude incidence rates/100,000 person-years or hazard ratios and 95% confidence intervals. Patients with T2DM are divided into
those with no antidiabetic medicines (T2DM-none), with oral medicines (T2DM-O), and those with insulin treatment (T2DM-I) and those with T1DM.
Multivariate 1: Adjusted for age, sex, height, and weight. Multivariate 2: Adjusted for age, sex, weight, height, previous fracture, rheumatoid arthritis,
glucocorticoid and alendronate use, and Charlson comorbidity index. Multivariate 3: As multivariate 2þ self-reported known fall injury. Multivariate 4:
Adjusted for age, sex, weight, height, previous fall injury, self-reported known fall injury, and Charlson comorbidity index.
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risk.(25–29) Indeed, in the present study, the presence of diabetes
retinopathy and other diabetes complications were more
frequent in patients with insulin treatment and were near
significantly associated with the risk of hip fracture. Further-
more, there are many hypotheses of bone-specific character-
istics in patients with severe diabetes such as deteriorated bone
matrix properties, low bone turnover, increased cortical
porosity, and altered bone marrow adiposity in patients with
obesity(16) that may explain some of the association between
diabetes and increased risk of fracture.
A previous meta-analysis revealed no specific sex effects of
diabetes on the risk of hip fracture.(14) Our results, although
presenting a similar pattern among men and women compared
with the whole cohort, showed on the contrary that men
without insulin treatment did not have increased risk of fractures
and men without any antidiabetic medications had in fact
decreased risk of hip fracture compared with those without
diabetes. In women, the risk of fractures was indeed increased
already in those with oral antidiabetic medications, and women
with antidiabetic medications had higher risk for fractures
compared with men within the same diabetes group. The
increased risk of fractures in women could be a result of
increased frequency of osteoporosis that is common among
postmenopausal elderly women, which in theory would lead to
more vulnerability for fractures in the case of falling.
Unfortunately, the diagnosis of osteoporosis is rarely registered
in the Swedish patient register and could not be properly
adjusted for in our study.
A somewhat surprising result was that the group of patients
with no antidiabetic medications (T2DM-none) who suffered
from many more comorbidities and a near significantly
increased risk of non-skeletal fall injuries still had reduced risk
of hip fracture compared with patients without diabetes. The
group with T2DM-none may consist of a variety of different
phenotypes of T2DM where some are patients with “mild
diabetes” and some are those with severe disease but with other
comorbidities preventing antidiabetic medications. However,
after multivariable adjustment for comorbidities, the patients
with T2DM-none did not have increased mortality compared
with the non-diabetic population (data not shown) and had less
frequency of diabetes retinopathy and diabetes complications
compared with the other diabetes groups, which strengthens
the supposition that a majority of these patients had indeed a
less severe diabetes.
Moreover, the risk of incident wrist fracture was not increased
in patients with diabetes, and in fact it was significantly
decreased in those with oral antidiabetics compared with
patients without diabetes. This may seem contradictory but is in
fact in accordance with previous studies,(11,21) and in the
Women’s Health Initiative Observational Study, the risk of lower
Fig. 2. Survival curves for time to hip fracture or time to non-skeletal fall injury (days). Patients divided into those with T2DM and insulin treatment
(T2DM-I), T2DM and oral antidiabetics (T2DM-O), and T2DMwithout any antidiabetic medicines (T2DM-none) compared with patients without diabetes.
(A–C) Adjusted for age, sex, weight, height, previous fracture, self-reported fall injury, rheumatoid arthritis, cortisone and alendronate use, and Charlson
morbidity index. (D–F) Adjusted for age, sex, weight, height, previous fall injury, self-reported known fall injury, and Charlson comorbidity index.
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arm fracture was the only fracture site that was not at all related
to diabetes.(9) However, in another large register-based study,
men and women with T2DM had indeed increased risk of wrist
fracture, although the association was only borderline signifi-
cant.(6) It should be emphasized that the quality of the register-
based data is higher regarding hip fractures (defined both by
diagnosis and surgical procedure) than for other fractures, which
infers that the observed associations between diabetes and
these fractures should be interpretedwith caution. Furthermore,
the present cohort consists of elderly patients andwrist fractures
usually occur earlier in life, as reflected by the relatively low
number of radius fractures in our study. Nevertheless, it may be
hypothesized that patients with diabetes have more severe falls
where the reflex of limiting the traumatic fall by the underarm is
impaired. Indeed, a previous study showed that most typical
osteoporotic upper-extremity fractures had its own specific
injury mechanism.(30)
There are limitations with this study. We did not have access to
measurements of HbA1c, BMD, physical activity, smoking, or
alcohol use in the databases, and we had to use a surrogate
marker of disease severity such as diabetes treatment to
characterize the patients. There may still be some misclassifica-
tionbetween type1 and type2diabetes, although theprevalence
of diabetes and the proportions of patients in each group
corresponded well with the expected prevalence of diabetes in
this age group. However, the subgroup defined as T1DM may
contain patients with T2DM that are misclassified in the registry,
especially with respect to the high mean age in each group
(where we normally do not expect to find patients with T1DM),
and the results for this subgroupmustbe interpreted carefully.On
the other hand, the results still support the hypothesis that the
risk of fractures increases along the road as diabetes deteriorates.
Another aspect of using treatment strategy as a surrogatemarker
of disease severity is that prescription of insulin may include a
number of other factors such as poor compliance with diet or
exercise and perhaps also poor compliance with measurements
of blood glucose, intake of insulin in the right doses and times,
that could not be adjusted for in the analyses. Nevertheless, a
strength of this study was that we used two different registers to
classify the patients with diabetes because all patients with
diabetes medications are found in the drug dispensatory register
(all prescriptions are registered electronically in Sweden) and
most patients were indeed registered at hospitals where given
diagnoses are transferred to the national patient register.
Vertebral fractures are often bypassed and not diagnosed and
entered in registers and could not be reliably studied in this
cohort and were therefore excluded. On the other hand, we
estimate that largely all hip fractures were detected because this
diagnosis is establishedat emergencyunits andhospitalwards, all
connected to the national registers, a method that has been
validated previously.(31)
In conclusion, this is the first large cohort study of elderly
patients with diabetes, classified according to diabetes treat-
ment, with available information regarding the risks of fractures
and non-skeletal fall injuries. Patients with insulin-treated T2DM
should indeed be considered as a high-risk group for future
fractures, but all patients with diabetes and any kind of
antidiabetic pharmacological treatment have increased risk of
other non-skeletal fall injuries andmay benefit from intervention
strategies primarily aiming at reducing the risk of falling.
The final explanation for the result is probably multifactorial
with some potential bone-specific alterations in patients with
severe diabetes, but most of all a complex result of increased
frailty and frequent falls owing to diabetic complications such as
visual impairment, neuropathy, renal failure, decreased balance
and muscle strength, hypoglycemic episodes, and severity of
other comorbidities.
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